NEFL and Parkinson disease: Moreover, the level of plasma NfL was significantly increased in patients with MSA and PSP when compared with PD (PSP, p < 0.0001; MSA, p < 0.0001) and controls (PSP, p < 0.0001; MSA, p < 0.0001).